High-purity array-specific protease is optimal for tag cleavage of tag-fused proteins!
Human rhinovirus type 14-derived 3C protease (HRV-3C Protease) recognizes the specific 8 amino acid sequence Leu-Glu-Val-Leu-Phe-Gln-Gly-Pro and cleaves between Gln and Gly. This product is a high-purity protein fused with a GST tag at the N-terminus and an 8×His tag at the C-terminus. 【Features】 - Cleaves tags from target proteins with the recognition sequence - After the reaction, removal of this enzyme is easy using the GST tag - Minimal buffer composition without additives such as surfactants - Ideal for sample preparation in protein science research
Inquire About This Product
basic information
Please feel free to contact us.
Price information
Desired inclusion price: 30,000 yen (excluding tax)
Price range
P2
Delivery Time
※The delivery time may vary depending on the quantity, so please feel free to contact us.
Applications/Examples of results
Protein Science Research
Detailed information
-
[Usage Example] Comparison of HRV-3C protease cleavage efficiency from various companies HRV-3C protease (products from various companies) was added to a substrate of 0.5 μg in amounts ranging from 1/10 to 1/400 (mass ratio of enzyme to substrate protein), reacted at 4°C for 16 hours, and the cleavage status was confirmed by SDS-PAGE.
catalog（3）
Download All Catalogs
Company information
Our company is a product development-oriented enterprise that utilizes biotechnology. We develop and manufacture in vitro diagnostic pharmaceuticals (such as pregnancy tests and ovulation tests), diagnostic drugs for environmental, food, and animal and plant diseases, and reagents for genetic engineering research, using our expertise in gene and antibody technology. We hold manufacturing registration and manufacturing and sales licenses for both human and animal products, with over 30 years of experience in the manufacture of in vitro diagnostic pharmaceuticals. Additionally, we are engaged in personalized medicine, advancing research and development of diagnostic drugs using genetic polymorphism analysis and gene expression analysis.
